Navigation Links
Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009
Date:5/6/2009

28,956 35,208 Goodwill 63,729 63,729 Deferred financing costs and other assets 991 1,159 Non-current deferred income tax assets, net 68,030 68,618 Total assets $721,225 $748,237 LIABILITIES AND STOCKHOLDERS' EQUITY ------------------------------------ Current liabilities: Current portion of long-term debt $129,234 $130,141 Accounts payable 29,037 22,879 Payables due to distribution agreement partners 43,297 91,451 Accrued salaries and employee benefits 14,173 11,850 Accrued expenses and other current liabilities 36,250 38,352 Total current liabilities 251,991 294,673 Long-term debt, less current portion - - Other long-term liabilities 40,786 41,581 Commitments and contingencies - - Stockholders' equity Common Stock, par value $0.01 per share, authorized 90,000,000 shares; issued 37,572,275 and 37,392,469 shares 375 374 Additional paid-in capital 322,047 319,976 Retained earnings 175,549 159,470 Accumulated other comprehensive gain 92 122 Treasury stock, at cost 2,815,369 and 2,716,010 shares (69,615) (67,959) Total stockholders' equity 428,448 411,983 Total liabilities and stockholders' equity $721,225 $748,237 PAR PHARMACEUTICAL COMPANIES, INC.
'/>"/>
SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... Farmington Company today announced it ... and visual identity helping brokers, consultants and companies ... to create greater benefit communication synergies. They unveiled ... empowering customers to better leverage Farmington Company’s industry-tested ... of the rebrand is the refreshed tagline: For ...
(Date:10/1/2014)... 2014 Beverly Hills licensed Clinical Psychologist ... celebrating 20 years of private practice in her Beverly ... to achieve greater joy and fulfillment in their relationships. ... signs and suggestions for anyone who suspects they are ... “Believe it or not, it’s not always easy to ...
(Date:10/1/2014)... 01, 2014 Diet Doc understands that many ... lose weight and their dieting attempts could be easily sabotaged ... hormone diet treatments into their programs as a ... see fast and effective weight loss results, it also allows ... habits to maintain their weight for the future. , Earlier ...
(Date:10/1/2014)... Raleigh, NC (PRWEB) October 01, 2014 ... combination of three drugs that target immune system proteins ... Surviving Mesothelioma has just posted details of the new ... the story now. , Researchers in the UWA ... TGF-ß, and anti-CTLA-4 drugs to mice with mesothelioma with ...
(Date:10/1/2014)... California (PRWEB) October 01, 2014 ... to benefit a very special cause. The campaign—“Buy ... support for Paws for Veterans, a nonprofit organization ... while also rescuing shelter dogs that would otherwise ... of featured products will support monthly donations of ...
Breaking Medicine News(10 mins):Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 2Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 3Health News:Diet Doc Announces Their New Version of the Hormone Diet Plan to Target, Attack and Burn Fat Without Dangerous Side Effects 4Health News:New Mesothelioma Study Says Mice Cured by Immuntherapy “Cocktail”, Reports Surviving Mesothelioma 2Health News:Nordic Naturals® Inspires Support for Paws for Veterans -- ‘Buy One Bottle. Help Two Heroes.’ Initiative Kicks Off October 1 2
... foundation set up by the Bill and Melinda Gates ... HIV-AIDS ambassador in India. // The officials said that ... the disease in the country.,The official release said that ... disease is a welcomed step in reducing the stigma ...
... is a country that wakes up to new things and accepts ... catching up.// Here doctors maintain there records in papers and are ... a job to document doctors’ patient records., ,In contrast, in ... maintained in the electronic format. ,MT industry in the US is ...
... benefit of doctors, hospitals and patients in mind a team ... will help doctors to prescribe prescriptions// to patients, based on ... Nicholson at Imperial College London led the study and made ... naturally by the body, in a group of rats before ...
... by the scientists at St. Jude Children’s Research Hospital ... suppressor gene resulted in aggressive leukemias.// Researchers have used ... and drug resistant nature of the acute lymphoblastic leukemia ... a mutation called Bcr-Abl and the loss of both ...
... of the money spent on buying over-the-counter cough medicines is ... so-called cough remedies may be ineffective. // It is stated ... year to these nonprescription cough medicines. ,There are many ... active ingredients in a limited number of strengths and combinations. ...
... accused China of removing organs from executed prisoners and ... their families//. ,There is increasing evidence, which ... for human transplantation purposes in an illegal way, according ... number of organs harvested from prisoners is currently unknown. ...
Cached Medicine News:Health News:Rising in career top charts is Medical transcription 2Health News:Mouse Models To Determine The Cause Of Aggressive Leukemia 2Health News:Mouse Models To Determine The Cause Of Aggressive Leukemia 3Health News:Executed Prisoner Organs For Sale In China: BTS Concerned 2
(Date:10/1/2014)... 1, 2014  Dyadic International, Inc. ("Dyadic") (OTCQX: ... proprietary technology used to develop and produce enzymes ... biopharmaceuticals, and industrial enzymes industries, today announced the ... Bioenergy for commercial scale production of Abengoa,s proprietary ... developed under Abengoa,s license agreement with Dyadic. ...
(Date:10/1/2014)... NEW YORK , October 1, 2014 ... and service provider for the medical industries, announced today the expansion ... New York City . genae Americas was incorporated ... is strategically centered in one of the highest concentrations of medical ... Philippe Kassab , President at genae Americas. "The expansion of genae ...
(Date:10/1/2014)... Oct. 1, 2014  Varian Medical Systems (NYSE: ... results for the fourth quarter of fiscal year 2014 ... 22, 2014.  The news release will be followed by ... p.m. PT.  The news release and a link to ... company website at: www.varian.com/investor .  To access the ...
Breaking Medicine Technology:Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 2Dyadic International Reports Licensing Payment For Commercial-Scale Production Of C1-Based Cellulase Enzymes 3genae Opens Offices in New York City 2Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2
Improve your refractive outcome, with AXIS II precision biometry A-scan. Biometry clinically proven as accurate as partial coherence interferometry while not limited by dense media....
... with graphic display and IOL power ... combination units include firmware module with ... II formulas. Audible tones increase in ... visual axis. Constant tone when alignment ...
... ISYSTEM-ABD ("I-cubed") is an exceptionally high ... analog oscilloscope (static deflection) display. This ... than low cost video monitors. Vitreous ... inflammatory cells, as well as tumor ...
... a sensitive B-scan system which quickly identifies ocular ... both eyes differ by more than 0.3 mm, ... suspected. The B5500 enables quick and easy identification ... bath or inserting shells under the lids. The ...
Medicine Products: